OptimizeRx Corporation

NasdaqCM OPRX

OptimizeRx Corporation Price to Book Ratio (P/B) on February 05, 2025

OptimizeRx Corporation Price to Book Ratio (P/B) is NA on February 05, 2025, a NA change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • OptimizeRx Corporation 52-week high Price to Book Ratio (P/B) is 2.45 on March 08, 2024, which is NA below the current Price to Book Ratio (P/B).
  • OptimizeRx Corporation 52-week low Price to Book Ratio (P/B) is 0.58 on November 15, 2024, which is NA below the current Price to Book Ratio (P/B).
  • OptimizeRx Corporation average Price to Book Ratio (P/B) for the last 52 weeks is 1.40.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
SV Wall Street
NasdaqCM: OPRX

OptimizeRx Corporation

Description

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

Similar companies

STRM

Streamline Health Solutions, Inc.

USD 3.78

-9.13%

PRVA

Privia Health Group, Inc.

USD 23.38

0.91%

NRC

National Research Corporation

USD 16.90

3.81%

CERT

Certara, Inc.

USD 14.11

1.80%

DH

Definitive Healthcare Corp.

USD 5.22

1.36%

HSTM

HealthStream, Inc.

USD 33.39

0.18%

ACON

Aclarion, Inc.

NA

NA

ACCD

Accolade, Inc.

USD 6.90

-0.14%

HQY

HealthEquity, Inc.

USD 111.97

0.00%

DOCS

Doximity, Inc.

USD 58.14

-1.04%

FORA

Forian Inc.

USD 2.44

3.39%

StockViz Staff

February 7, 2025

Any question? Send us an email